A double-blind randomized phase 3 clinical trial led by Dana-Farber Cancer Institute researchers and conducted across several hundred cancer centers in the U.S. tested the addition of high-dose ...
February 4, 2009 — Does adjuvant chemotherapy in patients with resected stage II and III colon cancer provide higher cure rates, or does it merely delay tumor recurrence? The answer to this ...
Study title: SOLARIS (Alliance A021703): A multicenter double-blind phase III randomized clinical trial of vitamin D combined with standard chemotherapy plus bevacizumab in patients with previously ...
Hosted on MSN
Everything You Need to Know About Colorectal Cancer?
Colorectal cancer starts in the colon or rectum, two key parts of the digestive system. It develops from abnormal cell growth in the lining of these organs, often beginning as small, noncancerous ...
The National Institute for Health and Care Excellence (NICE) has recommended nivolumab (Opdivo) plus ipilimumab (Yervoy) for some people in England with advanced colorectal cancer. The treatment is ...
The most common type of colon cancer is adenocarcinoma, which usually has a favorable outcome if diagnosed and treated early. Screening is an important tool for a prompt diagnosis. Colorectal cancer ...
The U.S. Food and Drug Administration (FDA) on Tuesday approved Bristol Myers Squibb & Co’s (NYSE:BMY) Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment of adult and pediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results